Sutent and Respiratory distress - a phase IV clinical study of FDA data

Summary:

Respiratory distress is reported as a side effect among people who take Sutent (sunitinib malate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Levaquin, and have Metastatic renal cell carcinoma.

The phase IV clinical study analyzes which people have Respiratory distress when taking Sutent. It is created by eHealthMe based on reports of 44,359 people who have side effects when taking Sutent from the FDA, and is updated regularly.

What is Sutent?

Sutent has active ingredients of sunitinib malate. It is often used in renal cell carcinoma. eHealthMe is studying from 44,554 Sutent users. Check the latest studies of Sutent.

What is Respiratory distress?

Respiratory distress (difficulty in breathing) is found to be associated with 1,563 drugs and 1,869 conditions by eHealthMe. Check the latest studies of Respiratory distress.

On Jul, 30, 2026

44,359 people reported to have side effects when taking Sutent.
Among them, 56 people (0.13%) have Respiratory distress.

Could Sutent cause Respiratory distress?

Among these 56 people:

How long have people been on Sutent when they have Respiratory distress? *

What is the gender of people who have Respiratory distress when taking Sutent? *

female: 22.22 %
male: 77.78 %

What is the age of people who have Respiratory distress when taking Sutent? *

What are other drugs people take besides Sutent? *

What are other side effects people have besides Respiratory distress? *

Dyspnea (difficult or laboured breathing): 14 people, 25.00%
Acute Kidney Failure: 9 people, 16.07%
Disease Progression: 9 people, 16.07%
Pneumonia: 8 people, 14.29%
Nausea (feeling of having an urge to vomit): 8 people, 14.29%
Pleural Effusion (water on the lungs): 7 people, 12.50%
Hypotension (abnormally low blood pressure): 6 people, 10.71%
Death: 6 people, 10.71%
Nausea And Vomiting: 6 people, 10.71%
Diarrhea: 6 people, 10.71%

What are the existing conditions these people have? *

Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 13 people, 23.21%
Gastrointestinal Stromal Tumor: 5 people, 8.93%
Renal Cell Carcinoma Stage Unspecified (kidney cancer in unknown stage): 4 people, 7.14%
Pain: 4 people, 7.14%
High Blood Pressure: 4 people, 7.14%
Renal Cancer Stage Iv (the tumour has spread to areas beyond gerota's fascia and extends into the adrenal gland on the same side of the body as the tumour, possibly to lymph nodes, but not to other parts of the body): 3 people, 5.36%
Metastases To Bone (cancer spreads to bone): 3 people, 5.36%
Diabetes: 2 people, 3.57%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 3.57%
Rickets (softening of bones): 1 person, 1.79%

* Approximation only. Some reports may have incomplete information.

Do you take Sutent and have Respiratory distress?

- Check whether Respiratory distress is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sutent:

Sutent (44,554 reports)

Browse all side effects of Sutent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Respiratory distress:

Respiratory distress (1,563 drugs)

Browse all the conditions that are associated with Respiratory distress:

Respiratory distress (1,869 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sunitinib malate (the active ingredients of Sutent) and Sutent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.